News for 'Sun Pharmaceutical'

Hydroxychloroquine exports only to foreign govts, not pvt cos

Hydroxychloroquine exports only to foreign govts, not pvt cos

Rediff.com10 Apr 2020

India will export anti-malarial drug hydroxychloroquine, high in demand globally, only to foreign governments and not to private companies, as the product is under prohibited or banned category of exports, sources said. Although exports of this medicine is completely banned, India has decided to export this anti-malarial drug in sync with its global commitment to deal with the coronavirus pandemic.

33 of 95 BSE100 cos INCREASED CAPEX

33 of 95 BSE100 cos INCREASED CAPEX

Rediff.com4 Feb 2021

Acquisitions may have played a role in much of the increase.

SBI stops deals related to Russian entities under sanctions

SBI stops deals related to Russian entities under sanctions

Rediff.com3 Mar 2022

State Bank of India, the nation's largest lender, has stopped processing transactions of Russian entities that have been sanctioned by the West over Moscow's invasion of Ukraine, sources said. To effect this, SBI has issued a circular as it fears that any transaction with entities or sectors under sanction will invite sanction on it as well, sources said. No transactions involving entities, banks, ports or vessels appearing on a US, European Union or United Nations sanctions list would be processed irrespective of the currency of the transaction, they said. Payments due to such entities have to be processed by other mechanism rather than through the banking channel, sources added.

'Market rally more likely to sustain than come to grinding halt'

'Market rally more likely to sustain than come to grinding halt'

Rediff.com1 Oct 2021

'Private banks are well-placed to deliver good performance over the next six months.'

Hard choice for MSME med device makers: Get licence by Oct 1 or shut shop

Hard choice for MSME med device makers: Get licence by Oct 1 or shut shop

Rediff.com27 Sep 2022

The transition of Class A and Class B medical device makers to the licensing regime by October 1 seems to be an uphill task with several small and medium manufacturers saying they are still awaiting the audit from the government authorities. If the licenses don't come through, either due to lack of audits or MSME units not clearing the audits, then a few thousand small-scale medical device units will face the issue of business continuity in three weeks. Class A medical devices are those with low to moderate risk to the patient or user (surgical dressings for example), while Class B medical devices refer to devices with moderate risks that require special controls (catheters for example).

Russia reaches out to Kerala for Sputnik V plant

Russia reaches out to Kerala for Sputnik V plant

Rediff.com29 Jul 2021

The government may look at areas around Thonnakkal, in Thiruvananthapuram district, for the facility. If successful, this would be one of the few sites of Sputnik V owned by Russian firms outside that country. Shine Jacob and Sohini Das report.

10 Stocks To Invest For The Long Term

10 Stocks To Invest For The Long Term

Rediff.com11 Apr 2023

The third-quarter financials didn't excite market watchers. But equity investors can still make money if they invest in the right stocks.

Pakistan flood death toll crosses 1,000-mark; countries step in with aid

Pakistan flood death toll crosses 1,000-mark; countries step in with aid

Rediff.com28 Aug 2022

Floods triggered by the torrential rain since June 14 have wreaked havoc, inundating a vast swathe of flat land in the south and southwest of the country.

Why Doctors Stopped Being Gods

Why Doctors Stopped Being Gods

Rediff.com15 Sep 2022

I got to know that every referred case for angiography and angioplasty got a kickback of Rs 5,000 and Rs 15,000 respectively. Seeing this trend, doctors started paying referring doctors Rs 1 lakh in advance and adjusting it as and when patients came in. This menace slowly spread its tentacles all over the medical field, including radiological diagnostics and biochemistry laboratories. For every test ordered, 20 per cent of the bill was given back to the referring doctor. This led to doctors recommending unnecessary tests. The pharmaceutical companies also saw burgeoning business. Acclaimed doctors were given televisions sets, refrigerators, air conditioners and cars depending upon the prescriptions. General practitioners would prescribe unnecessary drugs, and were given returns in cash. A fascinating excerpt from Dr Upendra Kaul's When The Heart Speaks.

Exports jump to $34.5 bn in Jan; trade deficit widens to $17.43 bn

Exports jump to $34.5 bn in Jan; trade deficit widens to $17.43 bn

Rediff.com15 Feb 2022

India's exports in January rose 25.28 per cent to $34.50 billion on account of healthy performance by mainly engineering, petroleum and gems and jewellery sectors, even as trade deficit widened to 17.43 billion, according to data released by the commerce ministry on Tuesday. Imports grew by 23.54 per cent to $51.93 billion during the month under review. Trade deficit, difference between imports and exports, stood at $14.50 bn in January 2021.

Coronavirus: No shortage of medicines, says govt

Coronavirus: No shortage of medicines, says govt

Rediff.com5 Mar 2020

'There is no shortage of any APIs (active pharmaceutical ingredients) in the country'

Delhi weekend curfew: Who will be exempted

Delhi weekend curfew: Who will be exempted

Rediff.com5 Jan 2022

A list of who all will be exempted during weekend curfew imposed in Delhi from Friday 10 pm to Monday 5 am in view of surge in COVID-19 cases.

India's economy could prove to be 'most resilient' in subregion over long term: UN

India's economy could prove to be 'most resilient' in subregion over long term: UN

Rediff.com29 Dec 2020

India's economy could prove to be the "most resilient" in the subregion of South and South-West Asia over the long term, according to a report by the UN, which says a positive but lower economic growth post COVID-19 pandemic and the country's large market will continue to attract investments. The report titled 'Foreign Direct Investment Trends And Outlook In Asia And The Pacific 2020/2021', and compiled by United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP), stated that inward FDI flows to South and South-West Asia slightly decreased by 2 per cent in 2019, from $67 billion in 2018 to $66 billion in 2019. The growth, however, was mainly driven by India, which accounted for 77 per cent of the total inflows to the subregion and received $51 billion in 2019, up 20 per cent from the previous year.

Coronavirus impact: Govt restricts exports of 13 APIs, formulations

Coronavirus impact: Govt restricts exports of 13 APIs, formulations

Rediff.com4 Mar 2020

Exports of 13 APIs - including paracetamol, tinidazole, metronidazole, vitamin B1, vitamin B6, vitamin B12, acyclovir, progesterone - along with formulations made from these APIs, would be restricted.

'Indian market one-eyed king in the land of the blind in 2022'

'Indian market one-eyed king in the land of the blind in 2022'

Rediff.com23 Sep 2022

'We have relatively strong growth and a healthy corporate earnings cycle as positives, but a worrisome current account deficit and high inflation as challenges.'

6 workers killed in fire in chemical factory in AP

6 workers killed in fire in chemical factory in AP

Rediff.com14 Apr 2022

More than 50 workers were at work in the night shift when the mishap occurred in unit-4.

How Shark Tank India 1 Winners Fared

How Shark Tank India 1 Winners Fared

Rediff.com14 Jan 2023

Of the 23 companies, eight have raised funds after Shark Tank India.

Iran keen to relaunch rupee-rial trade for exporting oil

Iran keen to relaunch rupee-rial trade for exporting oil

Rediff.com19 Mar 2022

Iran has offered to help India meet its energy needs by relaunching rupee-rial trade for export of oil and gas, said Iranian ambassador to India Ali Chegeni. Chegeni said if both the countries resume rupee-rial trade, bilateral trade can touch $30 billion. Iran used to be India's second largest oil supplier but New Delhi had to halt imports after the former US president Donald Trump withdrew from the nuclear deal with Iran and re-imposed sanctions on its oil exports.

'I would have been the king of limited overs cricket'

'I would have been the king of limited overs cricket'

Rediff.com7 Apr 2023

'I am not envious of those who are making millions. It's their era and I had my era.'

Why Chinese imports are likely to continue

Why Chinese imports are likely to continue

Rediff.com26 Jun 2020

Indian auto and pharma industries import several critical components and raw materials from China.

Bharat Biotech's Covaxin vaccine cleared by special panel

Bharat Biotech's Covaxin vaccine cleared by special panel

Rediff.com2 Jan 2021

Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research.

Senior bureaucrat P D Vaghela appointed TRAI chairman

Senior bureaucrat P D Vaghela appointed TRAI chairman

Rediff.com28 Sep 2020

He has been appointed as the TRAI chief for three years or till he attains the age of 65.

3rd wave: Govt creating 30-day stock of key Covid medicines

3rd wave: Govt creating 30-day stock of key Covid medicines

Rediff.com26 Jul 2021

'The Centre is planning to procure five million vials of Remdesivir ahead of the third wave. What's better is that this time, the government is paying us in advance,' said a senior executive of a Mumbai-based pharma player which makes Remdesivir. Sohini Das reports.

Share of family-owned firms in total market capitalisation rises to 64.5%

Share of family-owned firms in total market capitalisation rises to 64.5%

Rediff.com4 Jan 2021

The growth was led by family-owned companies and business groups with presence in pharmaceuticals, information technology services, and consumer products.

FTA: UK, India not working towards Diwali deadline

FTA: UK, India not working towards Diwali deadline

Rediff.com14 Oct 2022

The free trade agreement (FTA) talks with India are no longer working towards a Diwali deadline though negotiations are progressing well, UK Trade Secretary Kemi Badenoch has said as New Delhi expressed confidence on Friday of an "early date" for a mutually beneficial deal. "There are ongoing negotiations as we know on the FTA. There is interest on both sides to see if we can work towards a deal, an FTA, that is beneficial to both the countries at an early date," external affairs ministry spokesperson Arindam Bagchi told reporters in New Delhi. It came as External Affairs Minister S Jaishankar spoke to his UK counterpart, James Cleverly, and referenced the Roadmap 2030 bilateral agreement signed between Prime Minister Narendra Modi and former UK PM Boris Johnson in May last year, with no specific reference to the FTA.

Rakesh Jhunjhunwala rejigs portfolio in Q2; ups stake in Lupin, Tata Motors

Rakesh Jhunjhunwala rejigs portfolio in Q2; ups stake in Lupin, Tata Motors

Rediff.com30 Oct 2020

The duo bought additional shares in pharmaceutical companies Lupin and Jubilant Life Sciences, along with Agro Tech Foods and NCC during Q2FY21

Biological E plans to make 100m Corbevax jabs per month from Feb 2022

Biological E plans to make 100m Corbevax jabs per month from Feb 2022

Rediff.com28 Dec 2021

Biological E Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022 which will enable the Hyderabad-based company to deliver 300 Million doses as promised to the Centre, BE said on Tuesday.

India's rich club grows to 1,103; Zepto's Kaivalya youngest in Hurun list

India's rich club grows to 1,103; Zepto's Kaivalya youngest in Hurun list

Rediff.com22 Sep 2022

One hundred and forty nine new individuals joined the rich list club of 1,103 Indians across 122 cities who cumulatively accumulated a wealth of Rs 100 trillion. Bengaluru -based Kaivalya Vohra, 19, of grocery delivery application Zepto is the youngest self-made and the youngest rich individual, according to IIFL Wealth Hurun India Rich List 2022. The report found 1,103 Indians with a networth of Rs 1,000 crore each - an increase of 62 per cent over five years. There are 221 billionaires (Rs 100 crore networth) in India on the 2022 list - down 16 compared with last year, while 13 people born in the 1990s made it to the list, all self-made.

'Urban Naxals' trying to enter Gujarat: Modi targets AAP

'Urban Naxals' trying to enter Gujarat: Modi targets AAP

Rediff.com10 Oct 2022

The Arvind Kejriwal-led AAP is trying to make inroads into BJP-ruled Gujarat where the assembly polls are due later this year.

Gujarat pharma hub hit by near-zero exports

Gujarat pharma hub hit by near-zero exports

Rediff.com15 Apr 2020

With the government asking the companies to operate with only 50 per cent staff strength, and exports dipping to almost zero, the truck and bus drivers idling at the petrol pump say they hardly have any work now. At a petrol pump on the deserted Bavla-Changodar highway near Ahmedabad in Gujarat, several trucks and buses are neatly parked in a row.

FDI inflows seen to grow further in the New Year

FDI inflows seen to grow further in the New Year

Rediff.com21 Dec 2021

A series of steps taken by the government to promote ease of doing business and liberalisation of foreign direct investment norms have helped India receive record FDI inflows so far this year, and implementation of measures like PM Gati Shakti, single window clearance and GIS-mapped land bank are expected to further push investments in 2022. Notwithstanding the global slowdown and the COVID-19 pandemic, total foreign direct investments into India rose to a record $81.72 billion in 2020-21. During April-July this fiscal, FDI (foreign direct investment) into the country increased by 62 per cent to $27.37 billion.

Ahmed Patel's son-in-law, Dino Morea's assets seized in PMLA case

Ahmed Patel's son-in-law, Dino Morea's assets seized in PMLA case

Rediff.com2 Jul 2021

The Enforcement Directorate has alleged that this is a bigger bank scam in volume than that of the Punjab National Bank fraud by fugitive diamantaires Nirav Modi and Mehul Choksi, as it involves fraud to the tune of about Rs 16,000 crore.

Sputnik V vaccine may be added to India's Covid armoury soon

Sputnik V vaccine may be added to India's Covid armoury soon

Rediff.com30 Mar 2021

'We expect to get the approval in the next few weeks,' says Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy's Laboratories (DRL).

Dom's Take: Atmanirbhar or Nirbhar Vaccine?

Dom's Take: Atmanirbhar or Nirbhar Vaccine?

Rediff.com25 Nov 2020

Dominic Xavier wonders if the PM will opt for the Indian-made COVID-19 vaccine for the sake of Atmanirbhar Bharat.

'Famotidine may become the next HCQ for Covid-19'

'Famotidine may become the next HCQ for Covid-19'

Rediff.com10 May 2020

Researchers at Northwell Health in New York are testing the effects on Famotidine (used in high intravenous doses) on Covid-19 patients as a potential treatment. After the hospital announced its clinical trials, it led to a drug shortage in the US. Back home, however, there has not been any surge in the demand for Famotidine yet.

Sputnik V jabs to be available in 9 more cities across India

Sputnik V jabs to be available in 9 more cities across India

Rediff.com17 Jun 2021

Russian COVID-19 vaccine Sputnik V vaccine will be available in nine more cities across India, including Bengaluru, Mumbai, Chennai, Visakhapatnam, Baddi, Kolhapur and Miryalaguda, informed the official twitter handle of Sputnik V.

Dom's Take: The race for COVID-19 vaccine

Dom's Take: The race for COVID-19 vaccine

Rediff.com17 Nov 2020

Dominic Xavier wonders when human beings can access the vaccine and terminate the mayhem caused by the coronavirus.

Indian pharma industry seen to grow 9-11% in FY22

Indian pharma industry seen to grow 9-11% in FY22

Rediff.com4 Jan 2022

The Indian pharma industry is estimated to grow at 9-11 per cent in 2021-22 and in the next few quarters, it will be driven by domestic and emerging markets, according to ratings agency ICRA. In a sample of 21 Indian pharmaceutical companies, ICRA said revenue growth was moderate at 6.4 per cent in the second quarter of FY22, down from 16 per cent in the first quarter of 2021-22. The normalisation of the base and pricing pressures in the US market were the major reasons for slowing growth momentum in Q2 FY22, even as growth under domestic and emerging markets remained healthy, ICRA said in a statement.

India crosses $400-bn milestone in exports

India crosses $400-bn milestone in exports

Rediff.com23 Mar 2022

The country's exports for the first time crossed the $400 billion mark in a fiscal on healthy performance by sectors such as petroleum products, engineering, gems and jewellery, and chemicals, according to the commerce ministry's data released on Wednesday. The merchandise exports rose by by 37 per cent to $400.8 billion in 2021-22 until March 21 against $292 billion in 2020-21. Previously, the outbound shipments had touched a record of $330.07 billion in 2018-19.

Governments should not become trigger-happy about lockdowns

Governments should not become trigger-happy about lockdowns

Rediff.com7 Jan 2022

Sure we understand that isolating affected communities is part of the pandemic protocol, but we don't wish our life and freedom to be tossed aside at the slightest excuse, states Shyam G Menon.